[{"Assets_0_Q1_USD":"8684359000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"22.97","EarningsPerShareDiluted_1_Q1_USD":"22.72","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"62808000.0","NetIncomeLossConverted_1_Q1_USD":"685912000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q1_USD":"571644000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q1_USD":"6293079000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"30196000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"29865000.0","filed":"20200508","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"BIO-RAD LABORATORIES, INC.","period":"20200331","qtrs":"0","uom":"USD"}]